Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Praziquantel cures schistosomiasis but tastes so bitter that young children spit it out or vomit it up—new research aims to finally fix that.
Doxycycline treats both acute and chronic Q fever, yet one course lasts two weeks and the other lasts years. The biology behind that gap reveals a lot about how infection and immunity interact.
Mebendazole reliably kills adult pinworms, but the cure often fails without simultaneous family dosing and a two-week retreatment. Here's the biology and evidence behind the full protocol.
Standard ivermectin doses scale with body weight, but that formula was built on lean study populations. In obesity, the math breaks down in ways worth understanding.
Doxycycline can burn the esophagus if it lodges there. Body position and water volume at dosing time change that risk substantially.
A landmark head-to-head trial suggests moxidectin suppresses the parasite behind river blindness longer than ivermectin, though it isn't a wholesale replacement yet.
Albendazole paired with ivermectin or DEC forms the backbone of global efforts against lymphatic filariasis, each drug attacking the parasite differently.
Praziquantel cures schistosomiasis reliably, but not equally. The parasite species, the worm's age, and even the patient's own immune system all shape the outcome.
Flooding raises real leptospirosis risk. Here's what the actual trials show about doxycycline as preventive treatment, and where the evidence runs thin.